Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

271 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Predictive markers for haematological toxicity of pemetrexed.
Kao SC, Phan VH, Clarke SJ. Kao SC, et al. Curr Drug Targets. 2010 Jan;11(1):48-57. doi: 10.2174/138945010790031072. Curr Drug Targets. 2010. PMID: 19839928 Review.
Clinical pharmacokinetics of docetaxel.
Clarke SJ, Rivory LP. Clarke SJ, et al. Clin Pharmacokinet. 1999 Feb;36(2):99-114. doi: 10.2165/00003088-199936020-00002. Clin Pharmacokinet. 1999. PMID: 10092957 Review.
Vinblastine pharmacokinetics in patients with non-small cell lung cancer given cisplatin.
Links M, Watson S, Lethlean K, Aherne W, Kirsten F, Clarke S, Law M, Friedlander M, Galettis P, McKeage MJ. Links M, et al. Cancer Invest. 1999;17(7):479-85. doi: 10.3109/07357909909032857. Cancer Invest. 1999. PMID: 10518192 Clinical Trial.
Life threatening laryngeal toxicity following treatment with combined chemoradiotherapy for nasopharyngeal cancer: a case report with review of the literature.
Baron-Hay S, Clifford A, Jackson M, Clarke S. Baron-Hay S, et al. Ann Oncol. 1999 Sep;10(9):1109-12. doi: 10.1023/a:1008388916920. Ann Oncol. 1999. PMID: 10572611 Review.
Open label, multi-centre phase II study of raltitrexed ('Tomudex') in patients with inoperable squamous-cell carcinoma of head and neck.
Clarke SJ, Zalcberg J, Olver I, Mitchell PL, Rischin D, Dalley D, Green M, Davidson YE. Clarke SJ, et al. Ann Oncol. 2000 Feb;11(2):239-41. doi: 10.1023/a:1008369629944. Ann Oncol. 2000. PMID: 10761765 Clinical Trial.
Clinical and preclinical pharmacokinetics of raltitrexed.
Clarke SJ, Beale PJ, Rivory LP. Clarke SJ, et al. Clin Pharmacokinet. 2000 Dec;39(6):429-43. doi: 10.2165/00003088-200039060-00004. Clin Pharmacokinet. 2000. PMID: 11192475 Review.
Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer.
Boyer MJ, Mitchell P, Goldstein D, Millward MJ, Olver IN, Clarke SJ, Richardson G, Davis I. Boyer MJ, et al. Lung Cancer. 2001 Apr;32(1):89-94. doi: 10.1016/s0169-5002(00)00207-5. Lung Cancer. 2001. PMID: 11282433 Clinical Trial.
271 results
Jump to page
Feedback